Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob MiceThomas Albrecht, Sibylle J. Hauske, Giancarlo Aldini et al.|Scientific Reports|2017Cited by 127
Identification and characterisation of carnostatine (SAN9812), a potent and selective carnosinase (CN1) inhibitor with in vivo activityJiedong Qiu, Aimo Kannt, Sibylle J. Hauske et al.|Amino Acids|2018Cited by 42
Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBROb/Ob miceJiedong Qiu, Benito Yard, Thomas Albrecht et al.|Journal of Molecular Medicine|2020Cited by 20
The <i>CNDP1</i> (CTG)<sub>5</sub> Polymorphism Is Associated with Biopsy-Proven Diabetic Nephropathy, Time on Hemodialysis, and Diabetes DurationThomas Albrecht, Sibylle J. Hauske, Shiqi Zhang et al.|Journal of Diabetes Research|2017Cited by 17
Carnosinase concentration, activity, and CNDP1 genotype in patients with type 2 diabetes with and without nephropathyShiqi Zhang, Sibylle J. Hauske, Thomas Albrecht et al.|Amino Acids|2019Cited by 15